Nursing facility
Steward Holy Family Hospital, INC.
Steward Holy Family Hospital, INC. was paid $1.06M by Medicaid between Jan 2018 and Feb 2024, across 33 billing codes. Its largest line is 99285, emergency room visit (most serious) — 34% of everything it billed.
33Billing provider infoSTEWARD HOLY FAMILY HOSPITAL, INC.
METHUEN, MA 01844
METHUEN, MA 01844
33aNPI1336452010assigned 07/22/2010
33bProvider typeSkilled Nursing Facility
28Total paid$1.06M
24GClaims16,193
24DCodes billed33
24AFirst – last monthJan 2018 – Feb 2024
Compared with peers
Next to other Skilled Nursing Facility providers in Massachusetts
Rank by total paid#38 of 400
Median peer was paid$58K
This provider vs. median18×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RENNA, JAMES controls 11+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,101 | $170K | |
| 2019 | 4,150 | $236K | |
| 2020 | 3,078 | $235K | |
| 2021 | 4,907 | $345K | |
| 2022 | 824 | $72K | |
| 2023 | 62 | $0.00 | |
| 2024incomplete | 71 | $5K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 34% | 1,215 | 900 | $361K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 1,215 | 980 | $298K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 1,194 | 988 | $229K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.0% | 541 | 422 | $43K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.4% | 889 | 670 | $26K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.3% | 243 | 202 | $14K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.2% | 347 | 262 | $13K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 268 | 247 | $12K |
| 71046 | Radiologic examination, chest; 2 views | 1.0% | 262 | 208 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,420 | 1,740 | $9K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 181 | 142 | $6K |
| 80053 | Comprehensive metabolic panel | <1% | 1,051 | 771 | $6K |
21 more codes
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 277 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 209 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,178 | $5K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 152 | $5K |
| 71045 | Radiologic examination, chest; single view | <1% | 92 | $4K |
| 84484 | <1% | 522 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 82 | $2K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 32 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 168 | $1K |
| 81001 | <1% | 745 | $1K | |
| 84600 | <1% | 121 | $1K | |
| 83690 | <1% | 169 | $624.74 | |
| 80076 | <1% | 113 | $509.70 | |
| 81025 | <1% | 115 | $440.03 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,839 | $324.35 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 45 | $287.00 |
| 81003 | <1% | 187 | $170.05 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 247 | $105.22 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 32 | $77.14 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 14 | $68.95 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 28 | $38.90 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRENNA, JAMES (CHIEF FINANCIAL OFFICER)
Parent organizationSTEWARD HEALTH CARE SYSTEM LLC
| Provider | Location | Paid |
|---|---|---|
| Steward Holy Family Hospital, INC. | Methuen, MA | $70.80M |
| Steward Good Samaritan Medical Center, INC. | Brockton, MA | $64.10M |
| Steward Carney Hospital, INC. | Dorchester Center, MA | $56.76M |
| Steward ST. Elizabeth's Medical Center of Boston, INC. | Boston, MA | $32.53M |
| Steward Norwood Hospital, INC. | Norwood, MA | $8.47M |
| Steward ST. Elizabeth's Medical Center of Boston, INC. | Boston, MA | $1.90M |
| New England Sinai Hospital, a Steward Family Hospital, INC. | Stoughton, MA | $136K |
| Steward Carney Hospital, INC. | Dorchester Center, MA | $52K |
| Steward Good Samaritan Medical Center, INC. | Brockton, MA | $29K |
| Morton Hospital, a Steward Family Hospital, INC. | Taunton, MA | $11K |
| Steward ST. Anne's Hospital Corporation | Fall River, MA | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.